Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sensory System Agents”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Testing effectiveness (Phase 2)Looking for participantsNCT06463028
What this trial is testing

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Faeth Therapeutics 40
Not applicableWithdrawnNCT01016028
What this trial is testing

Chemotherapy-Induced Peripheral Neuropathy Survey

Who this might be right for
Breast CancerColorectal CancerMyeloma+1 more
M.D. Anderson Cancer Center
Early research (Phase 1)UnknownNCT04309084
What this trial is testing

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

Who this might be right for
Multiple MyelomaNeoplasm, Plasma CellNeoplasms by Histologic Type+17 more
Celularity Incorporated 29
Testing effectiveness (Phase 2)Study completedNCT06253806
What this trial is testing

Stellate Ganglion Block for COVID-induced Parosmia

Who this might be right for
COVID-19-Induced Parosmia
Washington University School of Medicine 48
Testing effectiveness (Phase 2)Study completedNCT04564027
What this trial is testing

A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer

Who this might be right for
Advanced Solid Tumours
AstraZeneca 54
Large-scale testing (Phase 3)Study completedNCT00773747
What this trial is testing

Study of Vorinostat (MK-0683) or Placebo, in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-088 AMN)

Who this might be right for
Multiple Myeloma
Merck Sharp & Dohme LLC 637
Not applicableStudy completedNCT02129595
What this trial is testing

Resveratrol and First-degree Relatives of Type 2 Diabetic Patients

Who this might be right for
Pre-diabetes
Maastricht University Medical Center 15
Early research (Phase 1)Ended earlyNCT04489420
What this trial is testing

Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM

Who this might be right for
Astrocytoma, Grade IVGiant Cell GlioblastomaGlioblastoma Multiforme+11 more
Celularity Incorporated 3
Early research (Phase 1)Study completedNCT01204723
What this trial is testing

Medications Development for the Treatment of Cannabis Related Disorders

Who this might be right for
Nicotine WithdrawalMarijuana DependenceCannabis Dependence+2 more
University of Virginia 63
Testing effectiveness (Phase 2)Looking for participantsNCT06993844
What this trial is testing

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsAdvanced Breast Cancer
Ensem Therapeutics 233
Large-scale testing (Phase 3)Looking for participantsNCT06752759
What this trial is testing

Nebulized Ketamine for the Treatment of Major Depressive Disorder

Who this might be right for
Severe DepressionModerate DepressionKetamine+14 more
Theresa Jacob, PhD, MPH 40
Testing effectiveness (Phase 2)Study completedNCT02634684
What this trial is testing

Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.

Who this might be right for
Schizophrenia
University of California, San Diego 82
Early research (Phase 1)Looking for participantsNCT07064122
What this trial is testing

AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)

Who this might be right for
Haematologic Neoplasms
AstraZeneca 72
Early research (Phase 1)Study completedNCT02577250
What this trial is testing

Ketamine Infusions for PTSD and Treatment-Resistant Depression

Who this might be right for
Depressive Disorder, Treatment-ResistantStress Disorders, Post-Traumatic
Minneapolis Veterans Affairs Medical Center 20
Large-scale testing (Phase 3)Study completedNCT03458078
What this trial is testing

Analgesic Efficacy of Two Adjuvants During Spinal Anaesthesia.

Who this might be right for
Pain, Postoperative
Centre de Maternité de Monastir 150
Large-scale testing (Phase 3)Study completedNCT05051735
What this trial is testing

PARASTOP - Paracetamol With Strong Opioids

Who this might be right for
Cancer PainCancer
Oslo University Hospital 204
Early research (Phase 1)Study completedNCT04178993
What this trial is testing

Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]

Who this might be right for
Methamphetamine Use Disorder
Craig Rush 8
Not applicableLooking for participantsNCT06835595
What this trial is testing

TMS-related Measures as Biomarker of Cognitive Impairment in PD

Who this might be right for
Parkinson Disease
Azienda Sanitaria Universitaria Integrata del Trentino 52
Post-approval studies (Phase 4)Study completedNCT05615948
What this trial is testing

Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression

Who this might be right for
Treatment Resistant DepressionMajor Depressive DisorderAnalgesia+10 more
Theresa Jacob, PhD, MPH 15
Testing effectiveness (Phase 2)Looking for participantsNCT05768139
What this trial is testing

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Who this might be right for
Breast CancerSolid Tumors, Adult
Eli Lilly and Company 880
Load More Results